Literature DB >> 24600581

Primary squamous cell carcinoma of the breast.

Sachin A Badge1, Nitin M Gangane1, Vitaladevnni B Shivkumar1, Satish M Sharma1.   

Abstract

Primary squamous cell carcinoma (SqCC) of the breast is a very rare tumor accounting for less than 0.1% of all invasive breast carcinomas. This is a very aggressive, hormone receptor negative and treatment refractory tumor with poor prognosis. We report a case of primary SqCC of the breast in a 72-year-old postmenopausal lady who presented with a lump in the right breast. The treatment of primary SqCC of the breast does not differ from other common histological types of breast cancer and may involve surgery, chemotherapy, hormonal therapy and radiation therapy. Clinical trials including large series of these rare tumors are needed to increase our knowledge and to improve patient's outcome.

Entities:  

Keywords:  Breast; carcinoma; squamous cell

Year:  2014        PMID: 24600581      PMCID: PMC3931217          DOI: 10.4103/2229-516X.125697

Source DB:  PubMed          Journal:  Int J Appl Basic Med Res        ISSN: 2229-516X


  8 in total

1.  Squamous cell carcinoma of breast.

Authors:  C S Pramesh; P Chaturvedi; A P Saklani; R A Badwe
Journal:  J Postgrad Med       Date:  2001 Oct-Dec       Impact factor: 1.476

Review 2.  Primary squamous cell carcinoma of the breast.

Authors:  Elias Moisidis; Sulman Ahmed; Hugh Carmalt; David Gillett
Journal:  ANZ J Surg       Date:  2002-01       Impact factor: 1.872

3.  [A resected case of squamous cell carcinoma of the breast successfully treated by FU plus cisplatin (CDDP) adjuvant therapy against recurrent metastases].

Authors:  Kiyoshi Hiramatsu; Kenji Kato; Akihiro Hirata; Hideki Matsuba; Tomohiro Hara; Takaaki Ito; Taishi Miyata; Takashi Akagawa; Yasushi Kutsuna; Yuichi Machiki; Susumu Fujioka
Journal:  Gan To Kagaku Ryoho       Date:  2007-03

4.  Squamous cell carcinoma of the breast: clinico-pathologic implications and outcome.

Authors:  K A Behranwala; N Nasiri; N Abdullah; P A Trott; G P H Gui
Journal:  Eur J Surg Oncol       Date:  2003-05       Impact factor: 4.424

5.  Pure primary squamous cell carcinoma of the breast: a rare presentation and clinicopathologic comparison with usual ductal carcinoma of the breast.

Authors:  Chakshu Gupta; Ashok K Malani; Robert T Weigand; Guatam Rangineni
Journal:  Pathol Res Pract       Date:  2006-02-23       Impact factor: 3.250

6.  Pure squamous carcinoma of the breast. Report of a case diagnosed by aspiration cytology.

Authors:  M Macia; J A Ces; E Becerra; A Novo
Journal:  Acta Cytol       Date:  1989 Mar-Apr       Impact factor: 2.319

7.  Squamous cell carcinoma of the breast: a clinical approach.

Authors:  J T Stevenson; D J Graham; A Khiyami; E G Mansour
Journal:  Ann Surg Oncol       Date:  1996-07       Impact factor: 5.344

8.  Acantholytic variant of squamous-cell carcinoma of the breast.

Authors:  V Eusebi; J Lamovec; M G Cattani; F Fedeli; R R Millis
Journal:  Am J Surg Pathol       Date:  1986-12       Impact factor: 6.394

  8 in total
  4 in total

Review 1.  A Comparative Review of Mixed Mammary Tumors in Mammals.

Authors:  Eman S A Saad; Jacqueline S Y Lam; Awf A Al-Khan; Mourad Tayebi; Michael J Day; Samantha J Richardson; Janine A Danks
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-11-28       Impact factor: 2.673

2.  Case Reports on Metaplastic Squamous Cell Carcinoma of the Breast and Treatment Dilemma.

Authors:  Anita Pandey; Kishor Joshi; Harry Moussouris; Gardith Joseph
Journal:  Case Rep Oncol Med       Date:  2019-09-18

3.  Recurrent copy number gains drive PKCι expression and PKCι-dependent oncogenic signaling in human cancers.

Authors:  Yi Liu; Verline Justilien; Alan P Fields; Nicole R Murray
Journal:  Adv Biol Regul       Date:  2020-09-12

4.  Prognostic factors for breast cancer squamous cell carcinoma and nomogram development for prediction: population-based research.

Authors:  Zhiyuan Cheng; Tao Han; Xiaotian Zhang; Xizhou Li; Hengyu Li; Jia Gu
Journal:  Transl Cancer Res       Date:  2019-09       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.